Keywords: تشدید COPD; COPD; Neutrophil PI3 kinase; COPD exacerbations; MMP-9; ROS
مقالات ISI تشدید COPD (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Serum periostin in patients hospitalized for COPD exacerbations
Keywords: تشدید COPD; ABGs; arterial blood gases; AECOPD; Acute Exacerbations of Chronic Obstructive Pulmonary Disease; BMI; Body Mass Index; COPD; Chronic Obstructive Pulmonary Disease; ELISA; enzyme linked immunosorbent assay; FEV1; forced expiratory volume in one second; Fi
Biological effects of p38 MAPK inhibitor losmapimod does not translate to clinical benefits in COPD
Keywords: تشدید COPD; p38 mitogen-activated protein kinase; COPD exacerbations; Anti-inflammatory therapy;
Reduced COPD Exacerbation Risk Correlates With Improved FEV1
Keywords: تشدید COPD; COPD exacerbations; COPD mechanisms; COPD pharmacology; BD; bronchodilator; dFEV1; between-group difference in change in predose (trough) FEV1 from the beginning to the end of the trial; HR; hazard ratio; non-BD; nonbronchodilator; PDE4; phosphodiesterase
Efficacy of erdosteine 900 versus 600 mg/day in reducing oxidative stress in patients with COPD exacerbations: Results of a double blind, placebo-controlled trial
Keywords: تشدید COPD; Erdosteine; Chronic obstructive pulmonary disease; COPD exacerbations; Airway inflammation; Oxidative stress; Antioxidants
Roflumilast added to triple therapy in patients with severe COPD: AÂ real life study
Keywords: تشدید COPD; COPD exacerbations; Phosphodiesterase-4 inhibitors; Combination therapy; Side effects; AECOPD; acute exacerbation of COPD; ICS; inhaled corticosteroids; LABA; long-acting β-agonist; LAMA; long-acting muscarinic antagonist; PDE-4; phosphodiesterase-4;
Keywords: تشدید COPD; COPD exacerbations; cost-effectiveness; early assisted discharge; hospital-at-home
Preventing COPD exacerbations with macrolides: A review and budget impact analysis
Keywords: تشدید COPD; COPD exacerbations; Macrolides; Prevention; Effectiveness; Safety; Budget impact
Statins and outcome after hospitalization for COPD exacerbation: A prospective study
Keywords: تشدید COPD; COPD; Statins; Cardiovascular comorbidities; Mortality; COPD exacerbations; Health-related quality of lifeBMI, body-mass index; CCIS, Charlson’s comorbidity index score; COPD, chronic obstructive pulmonary disease; ECOPD, exacerbation of COPD; FEF25-75, f
Il percorso diagnostico-assistenziale della broncopneumopatia cronica ostruttiva riacutizzata in Medicina Interna
Keywords: تشدید COPD; COPD exacerbations; Management; Diagnostic testing;
Impacto de las agudizaciones e ingresos en la EPOC
Keywords: تشدید COPD; Agudizaciones de la EPOC; Hospitalizaciones; Función pulmonar; Calidad de vida; Carga económica; Mortalidad; COPD exacerbations; Hospitalizations; Pulmonary function; Quality of life; Economic burden; Mortality;
Auditoria clÃnica de los pacientes hospitalizados por exacerbación de EPOC en España (estudio AUDIPOC): método y organización del trabajo
Keywords: تشدید COPD; EPOC; Exacerbaciones EPOC; AuditorÃa clÃnica; Mortalidad; Reingresos; COPD; COPD exacerbations; Clinical audit; Mortality; Readmissions;
Cough and Sputum Production Are Associated With Frequent Exacerbations and Hospitalizations in COPD Subjects
Keywords: تشدید COPD; airway mucus; chronic bronchitis; COPD; COPD exacerbations; GOLD; Global Initiative for Chronic Obstructive Lung Disease; ICS; inhaled corticosteroid; LABA; long-acting β2-agonist; OR; odds ratio;
Sputum color as a marker of acute bacterial exacerbations of chronic obstructive pulmonary disease
Keywords: تشدید COPD; COPD exacerbations; Sputum purulence; Lung function;
Sputum substance P and neurokinin A are reduced during exacerbations of chronic obstructive pulmonary disease
Keywords: تشدید COPD; Substance P; Neurokinin A; Tachykinins; Sputum; COPD; COPD exacerbations;